PROSTATE CANCER
 
What do recent studies tell us about finasteride and PCa?
"The relevant professional associations in the field of medicine and/or urology must do their part to inform and educate their members about the appropriate use of finasteride and PSA to eliminate avoidable morbidity and mortality from prostate cancer," writes Badar M. Mian, MD.
Read his column
ADVERTISEMENT
 
Challenging case: Hematuria in man with a history of prostate Ca
A 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.
Learn more
ADVERTISEMENT
 
Salvage LND may help delay recurrence
A preliminary study of the use of salvage lymph node dissection in patients with nonmetastatic, castration-resistant prostate cancer indicates the potential to delay disease recurrence as well as the use of systemic therapies through this approach.
Get the data
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES
 
Prostate cancer in 9/11 responders: Study explores mechanism of action
Fat in abdomen, thigh linked to higher risk of aggressive prostate cancer
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont